Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy.

Suppr

超能文献

作者信息

Stenson R E, Flamm M D, Harrison D C, Hancock E W

出版信息

Am J Cardiol. 1973 Jun;31(6):763-73. doi: 10.1016/0002-9149(73)90012-x.

DOI:10.1016/0002-9149(73)90012-x

PMID:4735938

Abstract

摘要

相似文献

Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy.

Am J Cardiol. 1973 Jun;31(6):763-73. doi: 10.1016/0002-9149(73)90012-x.

Symptomatic prognosis in patients with idiopathic hypertrophic subaortic stenosis (IHSS).

Am J Med. 1973 Jul;55(1):15-24. doi: 10.1016/0002-9343(73)90145-9.

Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol.肌肉型主动脉瓣下狭窄。用普萘洛尔预防流出道梗阻。

Circulation. 1968 Nov;38(5):846-58. doi: 10.1161/01.cir.38.5.846.

Propranolol.普萘洛尔

Dis Mon. 1974 Oct:1-31. doi: 10.1016/s0011-5029(74)80002-7.

Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.原发性高血压中的β-肾上腺素能阻滞剂。普萘洛尔对血流动力学参数和血浆肾素活性的影响。

Acta Med Scand Suppl. 1973;550:1-40.

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.维拉帕米疗法：肥厚型心肌病药物治疗的新方法。I. 血流动力学效应。

Circulation. 1979 Dec;60(6):1201-7. doi: 10.1161/01.cir.60.6.1201.

Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.原发性高血压患者急性和长期β-肾上腺素能阻滞剂的血流动力学效应

Acta Med Scand. 1974 Jul-Aug;196(1-2):27-34. doi: 10.1111/j.0954-6820.1974.tb00962.x.

Acute haemodynamic effects of practolol in patients with idiopathic hypertrophic subaortic stenosis.心得宁对特发性肥厚性主动脉瓣下狭窄患者的急性血流动力学影响。

Br Heart J. 1973 Feb;35(2):152-8. doi: 10.1136/hrt.35.2.152.

Modification of cardiovascular responses by propranolol.普萘洛尔对心血管反应的影响

Br Heart J. 1967 May;29(3):310-6. doi: 10.1136/hrt.29.3.310.

Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade.

Circulation. 1967 May;35(5):847-51. doi: 10.1161/01.cir.35.5.847.

引用本文的文献

Current and emerging medical and surgical therapy in hypertrophic cardiomyopathy.肥厚型心肌病的当前及新兴药物与手术治疗

J Cardiovasc Imaging. 2025 Sep 24;33(1):13. doi: 10.1186/s44348-025-00050-9.

Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》

Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.

Hemodynamics in Left-Sided Cardiomyopathies.左心心肌病的血流动力学

Rev Cardiovasc Med. 2024 Dec 24;25(12):455. doi: 10.31083/j.rcm2512455. eCollection 2024 Dec.

Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies.肥厚型心肌病心源性休克的个体化治疗：探索新兴策略

J Cardiovasc Dev Dis. 2024 Dec 11;11(12):401. doi: 10.3390/jcdd11120401.

Evolving Strategies for the Management of Obstructive Hypertrophic Cardiomyopathy.梗阻性肥厚型心肌病的治疗策略进展。

J Card Fail. 2024 Sep;30(9):1136-1153. doi: 10.1016/j.cardfail.2024.04.024. Epub 2024 May 20.

Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification.肥厚型心肌病的影像学检查：不仅仅是风险分层。

Heart Fail Clin. 2023 Oct;19(4):419-428. doi: 10.1016/j.hfc.2023.03.004. Epub 2023 Apr 29.

The medical treatment of cardiogenic shock.心源性休克的药物治疗。

J Intensive Med. 2023 Jan 19;3(2):114-123. doi: 10.1016/j.jointm.2022.12.001. eCollection 2023 Apr 30.

Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.肥厚型心肌病：诊断、预后和治疗的最新综述。

Heart Fail Rev. 2019 Jul;24(4):439-459. doi: 10.1007/s10741-019-09775-4.

Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.肥厚型心肌病：诊断、风险分层与治疗

CMAJ. 2013 Feb 5;185(2):127-34. doi: 10.1503/cmaj.120138. Epub 2012 Oct 29.

Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.

Tex Heart Inst J. 1995;22(2):126-33.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验